Collegium Pharmaceutical Inc (COLL)
37.56
+0.56
(+1.53%)
USD |
NASDAQ |
May 07, 14:01
Collegium Pharmaceutical Shareholders Equity (Quarterly): 195.43M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 195.43M |
| September 30, 2023 | 178.87M |
| June 30, 2023 | 200.80M |
| March 31, 2023 | 179.73M |
| December 31, 2022 | 194.84M |
| September 30, 2022 | 197.19M |
| June 30, 2022 | 197.61M |
| March 31, 2022 | 196.08M |
| December 31, 2021 | 202.93M |
| September 30, 2021 | 251.09M |
| June 30, 2021 | 253.07M |
| March 31, 2021 | 170.04M |
| December 31, 2020 | 186.03M |
| September 30, 2020 | 172.69M |
| June 30, 2020 | 155.77M |
| March 31, 2020 | 141.06M |
| December 31, 2019 | 87.43M |
| September 30, 2019 | 84.26M |
| June 30, 2019 | 85.82M |
| Date | Value |
|---|---|
| March 31, 2019 | 86.35M |
| December 31, 2018 | 91.58M |
| September 30, 2018 | 70.78M |
| June 30, 2018 | 82.68M |
| March 31, 2018 | 90.82M |
| December 31, 2017 | 104.08M |
| September 30, 2017 | 96.27M |
| June 30, 2017 | 95.51M |
| March 31, 2017 | 114.37M |
| December 31, 2016 | 134.91M |
| September 30, 2016 | 74.32M |
| June 30, 2016 | 98.66M |
| March 31, 2016 | 121.74M |
| December 31, 2015 | 85.07M |
| September 30, 2015 | 93.56M |
| June 30, 2015 | 102.42M |
| March 31, 2015 | 34.45M |
| December 31, 2014 | -12.24M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
84.26M
Minimum
Sep 2019
253.07M
Maximum
Jun 2021
175.30M
Average
186.03M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 387.88M |
| Immunogen Inc (DELISTED) | 561.60M |
| AnaptysBio Inc | 88.10M |
| Recursion Pharmaceuticals Inc | 463.44M |
| Nuvalent Inc | 700.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.143B |
| Total Liabilities (Quarterly) | 947.88M |
| Debt to Equity Ratio | 3.414 |
| Current Ratio | 1.174 |
| Net Debt Paydown Yield | 1.15% |